SUBJECTS : Neuro-oncology | Oncology | Neurology | Cancer | Central Nervous Syste
LATEST MANUSCRIPTS IN Neuro-Oncology Advances
- William C Chen, Calixto-Hope G Lucas, Stephen T Magill, C Leland Rogers, David R Raleigh. Radiotherapy and radiosurgery for meningiomas. Neuro-oncology advances. 2023, 5 (Suppl 1): i67-i83
Cited : 3Read More - Karan R Chadda, Palma Solano-Páez, Sara Khan, Mercedes Llempén-López, Poe Phyu, Gail Horan, Jamie Trotman, Patrick Tarpey, Craig Erker, Holly Lindsay, Dilys Addy, Thomas S Jacques, Kieren Allinson, Barry Pizer, Annie Huang, Matthew J Murray. Embryonal tumor with multilayered rosettes: Overview of diagnosis and therapy. Neuro-oncology advances. 2023, 5 (1): vdad052Cited : 0Read More
- Yang Yu, Xiaoli Lu, Yidi Yao, Yongsheng Xie, Yan Ren, Liang Chen, Ying Mao, Zhenwei Yao, Qi Yue. A 2-step prediction model for diagnosis of germinomas in the pineal region. Neuro-oncology advances. 2023, 5 (1): vdad094Cited : 0Read More
- Jill K Jones, Hengshan Zhang, Anne-Marie Lyne, Florence M G Cavalli, Wafa E Hassen, Kevin Stevenson, Reb Kornahrens, Yuanfan Yang, Sean Li, Samuel Dell, Zachary J Reitman, James E Herndon, Jacob Hoj, Ann Marie Pendergast, Eric M Thompson. ABL1 and ABL2 promote medulloblastoma leptomeningeal dissemination. Neuro-oncology advances. 2023, 5 (1): vdad095Cited : 0Read More
- Ameeta Retzer, Elin Baddeley, Stephanie Sivell, Hannah Scott, Annmarie Nelson, Helen Bulbeck, Kathy Seddon, Robin Grant, Richard Adams, Colin Watts, Olalekan Lee Aiyegbusi, Pamela Kearns, Samantha Cruz Rivera, Linda Dirven, Melanie Calvert, Anthony Byrne. Development of a core outcome set for use in adult primary glioma phase III interventional trials: A mixed methods study. Neuro-oncology advances. 2023, 5 (1): vdad096Cited : 1Read More
- Bronwen E Foreman, Trey C Mullikin, Scott R Floyd, Chris R Kelsey, Mallika P Patel, Katherine B Peters, John P Kirkpatrick, Zachary J Reitman, Eugene J Vaios. Long-term outcomes with reduced-dose whole-brain radiotherapy and a stereotactic radiosurgery boost for primary central nervous system lymphoma. Neuro-oncology advances. 2023, 5 (1): vdad097Cited : 1Read More
- David J Segar, Joshua D Bernstock, Sumientra Rampersad, Wenya Linda Bi, Omar Arnaout, Gregory K Friedman, E Antonio Chiocca. Intracranial stimulation for brain cancer-The case for implantable, intracranial tumor treating fields. Neuro-oncology advances. 2023, 5 (1): vdad100Cited : 0Read More
- Jonathan H Sussman, Jason Xu, Nduka Amankulor, Kai Tan. Dissecting the tumor microenvironment of epigenetically driven gliomas: Opportunities for single-cell and spatial multiomics. Neuro-oncology advances. 2023, 5 (1): vdad101Cited : 0Read More
- Olga Kim, Madison Butler, Zach Sergi, Robert W Robey, Meili Zhang, Raj Chari, Ying Pang, Guangyang Yu, Wei Zhang, Hua Song, Dionne Davis, Robert G Hawley, Xinyu Wen, Herui Wang, Martha Quezado, Bao Tran, Mythili Merchant, Alice Ranjan, Frank B Furnari, Javed Khan, Mark R Gilbert, Christopher Ryan Miller, Michael M Gottesman, Yves Pommier, Jing Wu. Combined inhibition of topoisomerase I and poly(ADP-ribose) polymerase: A synergistic therapeutic strategy for glioblastoma with phosphatase and tensin homolog deficiency. Neuro-oncology advances. 2023, 5 (1): vdad102Cited : 1Read More
- Anudeep Yekula, Tiffaney Hsia, Robert R Kitchen, Sudipto K Chakrabortty, Wei Yu, Syeda M Batool, Brian Lewis, Antoni J Szeglowski, Ralph Weissleder, Hakho Lee, Andrew S Chi, Tracy Batchelor, Bob S Carter, Xandra O Breakefield, Johan Skog, Leonora Balaj. Longitudinal analysis of serum-derived extracellular vesicle RNA to monitor dacomitinib treatment response in EGFR-amplified recurrent glioblastoma patients. Neuro-oncology advances. 2023, 5 (1): vdad104Cited : 0Read More
- Christoph Oster, Teresa Schmidt, Sarina Agkatsev, Lazaros Lazaridis, Christoph Kleinschnitz, Ulrich Sure, Björn Scheffler, Sied Kebir, Martin Glas. Are we providing best-available care to newly diagnosed glioblastoma patients? Systematic review of phase III trials in newly diagnosed glioblastoma 2005-2022. Neuro-oncology advances. 2023, 5 (1): vdad105Cited : 1Read More
- Mame Daro Faye, Jacob Easaw, Paula De Robles, Raman Agnihotram, Alexander Torres-Vasquez, Frederic Lamonde, Kevin Petrecca, Scott Owen, Valerie Panet-Raymond, George Shenouda, Luis Souhami, Maryam Azam, Bushra Hossain, Jad Alkass, Siham Sabri, Bassam Abdulkarim. Phase II trial of concurrent sunitinib, temozolomide, and radiotherapy with adjuvant temozolomide for newly diagnosed MGMT unmethylated glioblastoma. Neuro-oncology advances. 2023, 5 (1): vdad106Cited : 1Read More
- Kendra A Adegbesan, Francesco Tomassoni Ardori, Sudhirkumar Yanpallewar, Sean P Bradley, Yogita Chudasama, Elizabeth Vera, Nicole Briceno, Amanda L King, Lino Tessarollo, Mark R Gilbert, Vivian A Guedes, DeeDee K Smart, Terri S Armstrong, Dorela D Shuboni-Mulligan. The sex-dependent impact of PER2 polymorphism on sleep and activity in a novel mouse model of cranial-irradiation-induced hypersomnolence. Neuro-oncology advances. 2023, 5 (1): vdad108Cited : 0Read More
- Yoshiki Arakawa, Yoshitaka Narita, Motoo Nagane, Kazuhiko Mishima, Yasuhito Terui, Hajime Yonezawa, Katsunori Asai, Noriko Fukuhara, Kazuhiko Sugiyama, Naoki Shinojima, Arata Aoi, Ryo Nishikawa. Karnofsky Performance Status and quality of life in patients with relapsed or refractory primary CNS lymphoma from a phase I/II study of tirabrutinib. Neuro-oncology advances. 2023, 5 (1): vdad109Cited : 0Read More
- Ryutaro Makino, Nayuta Higa, Toshiaki Akahane, Hajime Yonezawa, Hiroyuki Uchida, Tomoko Takajo, Shingo Fujio, Mari Kirishima, Taiji Hamada, Hitoshi Yamahata, Kiyohisa Kamimura, Takashi Yoshiura, Koji Yoshimoto, Akihide Tanimoto, Ryosuke Hanaya. Alterations in and are associated with the localization of contrast-enhancing lesions in glioblastoma. Neuro-oncology advances. 2023, 5 (1): vdad110Cited : 0Read More
